Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study — Stella

Recruiting

Back to Alopecia Areata trials

Trial locations(1 site)

China

Second Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou, Zhejiang

Key details

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment target

~150 participants

Started

July 2024

Primary completion

December 2026

Age range

2 Years – 80 Years

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov